SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-22-017102
Filing Date
2022-05-02
Accepted
2022-05-02 17:08:17
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ljpc-10ka_20211231.htm   iXBRL 10-K/A 878012
2 EX-31.3 ljpc-ex313_6.htm EX-31.3 9672
3 EX-31.4 ljpc-ex314_29.htm EX-31.4 9708
  Complete submission text file 0001564590-22-017102.txt   1147059

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20211231.xsd EX-101.SCH 5641
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20211231_lab.xml EX-101.LAB 30991
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20211231_pre.xml EX-101.PRE 18617
8 EXTRACTED XBRL INSTANCE DOCUMENT ljpc-10ka_20211231_htm.xml XML 9415
Mailing Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451
Business Address 201 JONES ROAD, SUITE 400 WALTHAM MA 02451 617-715-3600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36282 | Film No.: 22883104
SIC: 2836 Biological Products, (No Diagnostic Substances)